References
- Gelbart B, Barnes C. Severe haemophilia and extreme prematurity-a case report. Haemophilia 2009;15:352-4. https://doi.org/10.1111/j.1365-2516.2008.01802.x
- Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8. https://doi.org/10.1136/adc.2004.050096
- Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001;112:264-74. https://doi.org/10.1046/j.1365-2141.2001.02362.x
- Kraft KE, Verlaak R, van Heijst AF, Novakova I, Brons PP. Management of haemophilia in three premature infants. Haemophilia 2008;14:378-80. https://doi.org/10.1111/j.1365-2516.2007.01645.x
- Yoo KY. Hemophilia. Korean J Pediatr 2006;49:821-9. https://doi.org/10.3345/kjp.2006.49.8.821
- Park YS. Recent advance of pharmacotherapy in hemophilia. J Korean Med Assoc 2009;52:1201-6. https://doi.org/10.5124/jkma.2009.52.12.1201
- Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8. https://doi.org/10.1056/NEJM196609082751003
- Chalmers EA. Haemophilia and the newborn. Blood Rev 2004;18:85-92. https://doi.org/10.1016/S0268-960X(03)00062-6
- Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia 1999;5:410-5. https://doi.org/10.1046/j.1365-2516.1999.00357.x
- Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 1998;4:850-3. https://doi.org/10.1046/j.1365-2516.1998.00201.x
- Bidlingmaier C, Bergmann F, Kurnik K. Haemophilia A in two premature infants. Eur J Pediatr 2005;164:70-2. https://doi.org/10.1007/s00431-004-1542-6
- Lorenzo JI, Lopez A, Altisent C, Aznar JA. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age. Br J Haematol 2001;113:600-3. https://doi.org/10.1046/j.1365-2141.2001.02828.x
- van der Bom JG, Mauser-Bunschoten EP, Fischer K, van den Berg HM. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Thromb Haemost 2003;89:475-9. https://doi.org/10.1055/s-0037-1613376
- Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007;109:4648-54. https://doi.org/10.1182/blood-2006-11-056291
- Mancuso ME, Graca L, Auerswald G, Santagostino E. Haemophilia care in children-benefits of early prophylaxis for inhibitor prevention. Haemophilia 2009;15 Suppl 1:8-14. https://doi.org/10.1111/j.1365-2516.2008.01947.x